Cysteinylglycine (Standard)

Cysteinylglycine (Standard) is the analytical standard of Cysteinylglycine. This product is intended for research and analytical applications. Cysteinylglycine is a dipeptide produced by the decomposition of extracellular glutathione catalyzed by γ-glutamyl transpeptidase. Cysteinylglycine is a highly reactive metabolite. Cysteinylglycine is currently mainly used in neurodegenerative diseases and breast cancer research[1][2][3][4].

Product Specifications

CAS Number

[19246-18-5]

Product Name Alternative

L-Cysteinylglycine (Standard) ; Cys-Gly (Standard) ; H-Cys-Gly-OH (Standard)

UNSPSC

12352100

Target

Endogenous Metabolite; Reference Standards

Related Pathways

Metabolic Enzyme/Protease; Others

Field of Research

Cancer; Neurological Disease

Smiles

O=C(O)CNC([C@H](CS)N)=O

Molecular Formula

C5H10N2O3S

Molecular Weight

178.21

References & Citations

[1]Houghton SC, et al. Plasma B-vitamin and one-carbon metabolites and risk of breast cancer before and after folicacid fortification in the United States. Int J Cancer. 2019 Apr 15;144 (8) :1929-1940.|[2]Steele M L, et al. Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells. Redox biology, 2013, 1 (1) : 441-445.|[3]Mansoor MA, et al. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem. 1992 Feb 1;200 (2) :218-29.|[4]Lin J, et al. Plasma cysteinylglycine levels and breast cancer risk in women. Cancer Res. 2007 Dec 1;67 (23) :11123-7.